Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients. Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients. Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed. Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient's evaluations and a careful consideration of expected benefits and potential adverse events are required.

Niscola, P., Tendas, A., Giovannini, M., Scaramucci, L., Cupelli, L., Ferrannini, M., et al. (2012). Pain management in hematological patients with major organ dysfunctions and comorbid illnesses. CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, 10(2), 135-147 [10.2174/187152512800388902].

Pain management in hematological patients with major organ dysfunctions and comorbid illnesses

Tendas, Andrea;Giovannini, Marco;Cupelli, Luca;de Fabritiis, Paolo
2012-06-01

Abstract

Background: Organ dysfunctions and medical complications, such as renal failure, liver impairment, coagulation disorders, cardiovascular and respiratory illnesses, may hamper an adequate pain management in haematological patients. Aim: To summarize current knowledge on pain management in hematological patients presenting major organ dysfunctions and comorbidity. We also attempted to provide recommendations to optimize analgesia and to minimize side effects in the setting of medically compromised and frail haematological patients. Methods: A systematic search of the literature, using relevant key words, was conducted in PubMed. Results and conclusions: Pain in hematological patients is a common symptom and is often multi-factorial. Most pharmacotherapeutic measures, including causal therapies, analgesics and adjuvant agents routinely applied in pain management, may also be used in the setting of clinical frailty and medical comorbidities; however, comprehensive clinical and functional patient's evaluations and a careful consideration of expected benefits and potential adverse events are required.
giu-2012
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15 - MALATTIE DEL SANGUE
English
Niscola, P., Tendas, A., Giovannini, M., Scaramucci, L., Cupelli, L., Ferrannini, M., et al. (2012). Pain management in hematological patients with major organ dysfunctions and comorbid illnesses. CARDIOVASCULAR & HEMATOLOGICAL AGENTS IN MEDICINAL CHEMISTRY, 10(2), 135-147 [10.2174/187152512800388902].
Niscola, P; Tendas, A; Giovannini, M; Scaramucci, L; Cupelli, L; Ferrannini, M; Brunetti, Ga; Bondanini, F; Palumbo, R; Perrotti, A; Romani, C; Carton...espandi
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/319060
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact